Did you know the "Magnificent Seven" moniker was meant as a warning, not an endorsement? Check out the risks and rewards of owning these dominant tech stocks.

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

For investors who plowed into stocks last week on speculation Trump’s policies will bolster the economy, the challenge is to ...

Expectations of who will gain, and who will lose, from the president-elect’s second term are already moving markets.

As the stock market rose, the bond market fell. Stocks roared to record highs Wednesday in the wake of news of Trump’s ...

One way to incentivize yourself to invest for the long term is to hold income-generating investments in your portfolio.

Crown Crafts (NASDAQ:CRWS – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on ...

Arcellx (NASDAQ:ACLX – Free Report) had its price objective boosted by Bank of America from $84.00 to $100.00 in a research ...

The S&P 500 is currently on a 46-week ATH streak, allowing for several weeks of interruption without declaring a streak ended ...

While both companies hold strong potential amid rising AI demand, AI models suggest that Nvidia stands out as the safer and ...

The S&P 500 rose 0.4% to cap its biggest weekly gain since early November 2023 and briefly crossed above the 6,000 level for ...